Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Medical Technologies Invests $345 Million In HPV Genotyping Chip

This article was originally published in The Gray Sheet

Executive Summary

China Medical Technologies is acquiring a human papillomavirus genotyping assay which it expects will generate up to $26.5 million in sales next year
Advertisement

Related Content

Far East Financials: Two Large Chinese Device Firms Report Mixed Growth
Far East Financials: Two Large Chinese Device Firms Report Mixed Growth
China Medical Reels In FISH Test Revenues; Q3 Sales Up 51%
China Medical Reels In FISH Test Revenues; Q3 Sales Up 51%
Mergers & Acquisitions In Brief
Mergers & Acquisitions In Brief
Hologic Gains HPV Test Technology In $580 Million Third Wave Purchase
CMT Targets Cancer, Prenatal Testing Markets In China
CMT Targets Cancer, Prenatal Testing Markets In China
Advertisement
UsernamePublicRestriction

Register

MT026663

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel